These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Inflammatory bowel disease after liver transplantation: a role for cytomegalovirus infection. Verdonk RC, Haagsma EB, Van Den Berg AP, Karrenbeld A, Slooff MJ, Kleibeuker JH, Dijkstra G. Scand J Gastroenterol; 2006 Feb; 41(2):205-11. PubMed ID: 16484126 [Abstract] [Full Text] [Related]
4. The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia. Kim JM, Kim SJ, Joh JW, Shin M, Moon JI, Jung GO, Choi GS, Kwon CH, Lee SK. Transplant Proc; 2010 Apr; 42(3):890-4. PubMed ID: 20430198 [Abstract] [Full Text] [Related]
10. Major infectious complications after orthotopic liver transplantation and comparison of outcomes in patients receiving cyclosporine or FK506 as primary immunosuppression. Hadley S, Samore MH, Lewis WD, Jenkins RL, Karchmer AW, Hammer SM. Transplantation; 1995 Mar 27; 59(6):851-9. PubMed ID: 7535482 [Abstract] [Full Text] [Related]
12. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation. Fan J, Meng XQ, Yang MF, Zhou L, Chen XM, Hu MJ, Fan WW, Ma WH, Li LJ. Hepatobiliary Pancreat Dis Int; 2006 Feb 27; 5(1):34-8. PubMed ID: 16481279 [Abstract] [Full Text] [Related]
13. Deferred versus prophylactic therapy with gancyclovir for cytomegalovirus in allograft liver transplantation. Lianghui G, Shusen Z, Tingbo L, Yan S, Weilling W, Anwei L. Transplant Proc; 2004 Jun 27; 36(5):1502-5. PubMed ID: 15251371 [Abstract] [Full Text] [Related]
15. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection? Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV. Liver Transpl; 2005 Jun 27; 11(6):700-4. PubMed ID: 15915496 [Abstract] [Full Text] [Related]
16. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment. Hazar V, Ugur A, Colak D, Saba R, Tezcan G, Kupesiz A, Karadogan I, Gultekin M, Yesilipek A, Undar L. Jpn J Infect Dis; 2006 Aug 27; 59(4):216-21. PubMed ID: 16936338 [Abstract] [Full Text] [Related]
17. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. van den Berg AP, Klompmaker IJ, Haagsma EB, Peeters PM, Meerman L, Verwer R, The TH, Slooff MJ. Clin Transplant; 1996 Apr 27; 10(2):224-31. PubMed ID: 8664524 [Abstract] [Full Text] [Related]